IBS Treatment With H1-receptor Antagonists.

Trial Profile

IBS Treatment With H1-receptor Antagonists.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 May 2013

At a glance

  • Drugs Ebastine (Primary)
  • Indications Irritable bowel syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 May 2013 Primary endpoint 'Clinical-response' has not been met according to results presented at Digestive Disease Week 2013.
    • 21 May 2013 Results presented at Digestive Disease Week 2013.
    • 21 May 2012 Actual patient number is 55 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top